This week, Walgreens Boots Alliance (WBA, $22.42) has been the talk of the town in the trading community, showcasing an impressive rise of +5.06%. Out of the 26 drugstore chains analyzed, WBA was among the top performers, aligning itself with the 50% of stocks in the industry that experienced an uptrend.
๐ Unlock the Potential of Trading with Walgreens Boots Alliance (WBA) Using AI! ๐ค๐
Walgreens Boots Alliance (WBA) has made headlines with its stellar weekly gain of +5.06%. If you're looking to capitalize on such opportunities, our AI trading tools are here to assist.
๐ "Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA)" provides insights into trading in downward trending markets, helping you make informed decisions during market declines.
๐ "Swing Trader: High Capitalization (TA)" focuses on high-cap stocks, potentially allowing you to optimize your trading strategy within the high-cap sector, where WBA operates.
With AI precision and insights, you can fine-tune your WBA trading strategy, reduce risks, and make data-driven decisions. Seize opportunities and embark on your journey to trading success with AI expertise! ๐๐๐ Discover the future of trading with AI-powered insights! ๐ผ๐ค
Earnings Insights ๐:
The earnings report unveiled on June 27 exhibited an EPS of $1.00, which fell short of the anticipated $1.08. Holding a strong 7.70M shares outstanding, WBA's current market cap is pegged at a solid $19.35 billion.
Dividend Alert ๐ฐ:
WBA shareholders were rewarded with a dividend payout of $0.48 per share, having a record date set for September 12, 2023. Those considering jumping into WBA stocks should note the ex-dividend date of August 18, 2023.
Industry Bigwigs ๐:
In the Drugstore Chains arena, a few names dominate the scene with Walgreens Boots Alliance and Rite Aid Corp being the most prominent ones.
Industry Snapshot ๐:
The drugstore chains industry is a cornerstone in the retail sector. Encompassing the sale of both prescription and non-prescription medications, as well as health and personal care products, this industry has shown resilience against economic downturns. Furthermore, some major chains have evolved to offer pharmacy benefits management services. Giants like CVS Health Corporation, alongside WBA, steer this ship, making the industry a mainstay in the market.
Market Capitalization Landscape ๐๏ธ:
Delving deeper into the market cap of the Drugstore Chains, the average stands at $2.96 billion. WBA comfortably sits atop this list with a valuation of $19.35 billion, while RLLVF ranks at the bottom with a mere $3.29K.
Price Dynamics ๐ข:
The weekly price movement in the industry remained static at 0%. However, the monthly and quarterly figures painted a gloomier picture, with dips of -9% and -2% respectively. While Rite Aid Corp made waves with a 21% spike, HEWA faced a slump, dropping by -20%.
Volume Play ๐:
The week saw an average volume dip of -3% across the industry. When analyzed on a broader scale, monthly volumes plummeted by -66%, but there was a silver lining with quarterly volumes rising by 49%.
Analyzing the Fundamentals ๐:
WBA's Trading Recap ๐: Over the past five trading sessions, WBA witnessed a gain of +5.50%, attracting an average daily volume of 913,236 shares. However, the stock faced a drawdown of -4.39% during this timeframe. WBA's earnings announcement on June 26, 2023, added to the overall market buzz.
As the trading week wrapped up, Walgreens Boots Alliance (WBA) emerged as a beacon for traders and investors in the Drugstore Chains Industry. Here's to more such bullish weeks! ๐๐ฅ
WBA saw its Momentum Indicator move above the 0 level on October 04, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned positive. In of the 97 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
WBA moved above its 50-day moving average on October 28, 2024 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for WBA crossed bullishly above the 50-day moving average on October 17, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where WBA advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 107 cases where WBA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for WBA moved out of overbought territory on October 21, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Moving Average Convergence Divergence Histogram (MACD) for WBA turned negative on October 25, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WBA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
WBA broke above its upper Bollinger Band on October 15, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.250) is normal, around the industry mean (5.704). P/E Ratio (32.848) is within average values for comparable stocks, (172.042). Projected Growth (PEG Ratio) (2.170) is also within normal values, averaging (1.915). Dividend Yield (0.086) settles around the average of (0.050) among similar stocks. P/S Ratio (0.117) is also within normal values, averaging (0.765).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. WBAโs price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WBAโs unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of drug store services
Industry DrugstoreChains